Skip to content

Effect of Dual-Task Training on Pediatric Oncology Patients

Evaluation of the Effect of Dual-Task Training on Muscle Strength, Balance, and Gait in Pediatric Oncology Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05118464
Enrollment
21
Registered
2021-11-12
Start date
2021-09-15
Completion date
2023-09-15
Last updated
2021-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

cancer, gait, postural balance, muscle strength

Brief summary

It is known that the treatment of children with cancer has negative effects on cognition, muscle strength, balance, and gait. Therefore, the aim of this study is to evaluate the effects of dual-task training, which is based on the principle of simultaneous performance of cognitive tasks and motor tasks, on muscle strength, balance, and gait.

Detailed description

With the increase in the incidence of cancer, the number of children who survived cancer is also increasing. Most studies on cancer survivors show that the disease and its treatment have side effects and long-term late effects on the musculoskeletal system, physical function, motor, and cognitive skills. Therefore, the aim of this study is to evaluate the effects of dual-task training, which is based on the principle of simultaneous performance of cognitive tasks and motor tasks, on muscle strength, balance, and gait. This study is planned to be the first study in which dual-task training is applied in children with cancer.

Interventions

Dual-task training includes simultaneous execution of motor and cognitive tasks. The motor tasks in this study will be walking, going up and downstairs, turning, throwing, and holding a ball. Cognitive tasks will be an n-back test, verbal fluency, remembering sequences of numbers, and performing simple summing.

Sponsors

Afyonkarahisar Health Sciences University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with pediatric cancer and inpatient and outpatient treatment in Hematology-Oncology Clinics for treatment, * Able to walk alone without any walking aid, * Children aged 6-18 will be included

Exclusion criteria

* Staying in an isolated room or at risk of infection (neutropenic, etc.), * Any orthopedic or neurological disorder that may prevent walking; * Having any mental disability that will prevent performing a cognitive task, * Individuals with malignant hypertension or unstable heart disease (eg, congestive heart failure) will not be included in the study.

Design outcomes

Primary

MeasureTime frameDescription
gait speed600 secondsGait speed is the time one takes to walk a specified distance on level surfaces over a short distance. It will be recorded in m/s.
balance300 secondsBalance is evaluated with Timed-up and Go Test. The time elapsed during the test is recorded in seconds.
Muscle strength600 secondsIsometric muscle strength will be evaluated with a hand-held dynamometer. It will be recorded in kg.

Countries

Turkey (Türkiye)

Contacts

Primary ContactEMEL TAŞVURAN HORATA, PhD
ethorata@gmail.com+905547759663

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026